Pharos Devices Announces Formation of Company to Develop Next Generation Wireless Breast Tumor Marker Technology

Share Article

The Pharos breast tumor marker technology will increase the effectiveness of breast cancer surgery.

Pharos Devices announced today the formation of the company to develop a next generation wireless breast cancer tumor marker technology. Pharos develops innovative sensing and localization products that make medical procedures more efficient, effective and mobile.

Their product, the TagFinder, is a handheld radio frequency reader that can detect markers embedded in the body. Its first application is detecting markers placed around breast lesions for surgical removal. This product eliminates the need for a day-of-surgery procedure that currently causes a significant number of operating room delays and cancellations. The TagFinder is in development with commercial release scheduled for 2014.

The target customers are the breast surgeons and radiologists in approximately 5,000 breast centers world-wide who perform more than a million breast lesion excisions annually. “The Pharos mission is to bring this innovative marker technology to patients and clinicians to improve the effectiveness of breast cancer treatment worldwide,” says Nancy Confrey, CEO of Pharos. “We’re excited to have a solution to a problem that has faced surgeons, radiologists and hospital administrators for years.”

About Pharos Devices
Pharos Devices is an early stage company that develops and markets innovative sensing and localization products that make medical procedures more efficient, effective and mobile. http://www.pharosdevices.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Adams
Visit website